Little evidence for benefit of interventions in the early stage of chronic kidney diseaseA new research review from the Agency for Healthcare Research and Quality (AHRQ) found no or limited evidence that interventions are beneficial to patients in the early stages of chronic kidney disease. The report evaluated the evidence regarding the potential benefits and harms of screening, monitoring, and treatment of adults in stage 1, 2, or 3 of the five stages of chronic kidney disease. The report authors noted that many knowledge gaps remain, and additional research should increase understanding about optimal approaches to chronic kidney disease screening, monitoring, and treatment. Chronic kidney disease affects more than 44 percent of U.S. adults over the age of 70.
The report, Chronic Kidney Disease Stages 1-3: Screening, Monitoring, and Treatment and many other materials are available on the AHRQ's Effective Health Care Program Web site at http://www.effectivehealthcare.ahrq.gov.